Clinical Trial Update: Liver Function After Intravenous Methylprednisolone Administration [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating liver function following intravenous methylprednisolone administration in Graves disease and Graves ophthalmopathy pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease
• Graves Ophthalmopathy

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Graves Disease, Graves Ophthalmopathy | Phase 4 | Status: COMPLETED